Abstract

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid

Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G

Issue: Nov/Dec 2017 - Volume 21, Number 6

Page(s): 500-512

Download in electronic PDF format for $75
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 1
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 2
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 3
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 4
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 5
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 6
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 7
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 8
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 9
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 10
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 11
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 12
  • To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Page 13

Abstract

Omeprazole is a proton pump inhibitor used to treat the symptoms of gastro esophageal reflux disease, ulcers, excess stomach acid, infection with Helicobacter pylori, and to control the gastric side effects of various drugs. The approved dosage forms in the U.S. are powder in compounding kits, delayed-release granules for oral suspension, oral delayed-release tablets, and oral delayed-release capsules. An extemporaneously compounded unsweetened oral liquid method, published in the International Journal of Pharmaceutical Compounding, was found to be commonly used by pharmacists. This project investigated the robustness of the compendium omeprazole high-performance liquid chromatographic assay in evaluating an oral liquid made from commercial delayed-release pellets, the potency of extemporaneously compounded solutions having a 1.125% v/v flavored versus unflavored samples stored at controlled cold temperatures at different time points, and examining the absorption spectrum of the flavoring agent. As part of the study, stability-indication testing was also conducted. The studies indicate that the chromatographic area under the plasma concentration-time curve of both study groups remained over 90% of the label claim during the follow-up period. The flavor did not significantly impact the pH of the oral liquid. This study further identified (1) an increase in resilient foam formation in the flavored liquid, potentially hindering dosing accuracy, (2) omeprazole is oxidized easily by 3% hydrogen peroxide, and (3) flavoring agent absorbs in an ultraviolet visible spectroscopy spectral range often used in assay detectors for quantification of drug molecules, and could interfere with assay protocols of the same.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2017
Pg. 500-512
Jan/Feb 2003
Pg. 48-50
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 504-510
Jan/Feb 2019
Pg. 58
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 124-128
Mar/Apr 1997
Pg. 90-92
Author(s): Allen Loyd V Jr
May/Jun 2023
Pg. 250-255
Sep/Oct 2006
Pg. 389
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 140-147
Jul/Aug 2017
Pg. 330-333
Mar/Apr 2007
Pg. 161
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 13-16
Author(s): Kloesel Lawson G
Sep/Oct 2019
Pg. 409
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 391
Author(s): Allen Loyd V Jr
Mar/Apr 2006
Pg. 139
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 164-166
Jul/Aug 2003
Pg. 288-291
Author(s): Glasnapp Andrew
Jul/Aug 2003
Pg. 313-319
Jan/Feb 2007
Pg. 74
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 458-460
Author(s): McElhiney Linda F